The BUZZZ this weekend is insane and word on the street is that theres are several MAJOR updates that will be unleashed this week to breakout EKNL in solid ?core? pick fashion.
EKNL IS?OUR MONSTER 2012 PICK TO?RIVAL DROPs $1.25 target (83,000% in gains)
As we have seen our 2011 monster Fuse Science (DROP) soar to hit our target of $1.25 (+83,000% gains) bang on soon after our special report was unleashed, EKNL?is on the right track to do the same
Definitely people are stoked after we raised our price targets in our Special Report this weekend and for very good reasons.
Get the SPECIAL report here and see what price target we now have on EKNL.
EKNL busted out of the gates last week soaring 200% since our alert at $0.04, and reveling several strategic initiatives - no doubt showing what was building over the past few months and much more to be seen.
EKNL announced a J.V. with NeuroVasc Clinical Inc.(NCI) to start distribution of FREMS in North America
EKNL just announced their first of many clinics that will be treating patients with their FREMS patented technology equipment. The Mayer Institute is world renowned for specializing in the treatment of Diabetics, and no doubt this is a HUGE score for EKNL and opens up the flood gates for many more clinics to be part of this FREMS technology ? we are sure we will be hearing much more details over the next few weeks.
EKNL is tightly held buy insiders and they are definitely not letting go of any shares at these super cheap prices, let alone anything under the dollar level.
EKNL only has 8 Million shares in the float and what we have also learned was that available for trading in the DTC is only 5.5 Million shares! This is insane and stock inventory is super thin making it more difficult each day to purchase any shares. We are already starting to see the effects of this super thin inventory.
Make sure to read the special report released this weekend ? a must read for this weeks trading.
Special Report Article except: ?It is estimated that there are 60 million diabetics in North American in 2012 and that number is climbing rapidly. Approximately 65% of diabetics will develop peripheral neuropathy?
ABOUT EKO INTERNATIONAL
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company? is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.
Compensation: Ourhotstockpicks has not been compensated for the profile of EKNL.
Ourhotstockpicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale.? An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Ourhotstockpicks may be buyers of features in the open market. Click here to view the full disclaimer
?
from your own site.
Source: http://www.ourhotstockpicks.com/eknl-huge-buzz-on-the-street-leading-to-a-major-update-this-week/
daylight saving time 2012 grapes of wrath silent house nfl mock draft project m rubio colts
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.